Skip to main content

Table 4 Multivariate survival analysis of the association between risk factors and adenomyosis recurrence

From: Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis

 

Observation period = 36 months

Exposure categories

Recurrence, n(%)

HR (95%CI)

aHR (95%CI)

P

Sugery-LNG-IUS

 No

22 (31.88%)

Ref

Ref

 

 Yes

2 (2.86%)

0.076(0.018–0.322)

0.07(0.016–0.31)

< .001

Concomitant OEM

 No

13(11.61%)

Ref

Ref

 

 Yes

11(40.74%)

3.98(1.78–8.89)

2.94(1.33–7.02)

.015

 Preoperative CA125, U/ml

-

1.00(0.99–1.01)

1.00(0.99–1.01)

.099

  1. Abbreviation: aHR Adjusted hazards ratio, LNG-IUS Levonorgestrel-releasing intrauterine device, OEM Ovarian endometrium, VAS Visual analog scale
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us